A 12-month gastric balloon is a temporary endoscopic weight-loss treatment designed to remain in the stomach longer than many standard balloon systems. The extended treatment window may provide more time for patients to work on portion control, meal structure, activity routines and long-term behaviour change.

For selected patients, this longer period can be useful. Weight loss treatment often requires repetition, support and time. A 12-month programme may allow patients to practise new habits through different seasons, travel periods, work schedules, family events and real-life challenges.

However, longer does not automatically mean better.

A longer-duration balloon still requires medical assessment, endoscopic placement, symptom monitoring, nutrition support, follow-up and planned removal. It should not be treated as a “set-and-forget” device. The patient still needs to remain engaged throughout the programme.

For international patients, the 12-month timeline creates additional planning needs. A year is long enough for travel plans, work, family circumstances, pregnancy plans or health status to change. This makes removal planning, medical documentation and follow-up arrangements essential before the balloon is placed.

What Is a 12-Month Gastric Balloon?

A 12-month gastric balloon is an intragastric balloon placed into the stomach during an endoscopic procedure and designed to remain for a longer period than many traditional 6-month balloons.

Depending on the device type and local protocol, some longer-duration balloons may allow volume adjustment during the treatment period. Others may follow a fixed-volume pathway.

The balloon is usually removed by endoscopy at the planned time.

Patients should receive specific information from the treating centre about:

• Device type
• Intended duration
• Fill material and volume
• Whether the balloon is adjustable
• Follow-up schedule
• Removal timing
• Emergency pathway
• Post-removal maintenance plan

Because device approvals and protocols differ between countries, patients should not rely only on general online information. The treating centre should explain the exact product being used and the rules that apply in that country.

How Is a 12-Month Balloon Different From a 6-Month Balloon?

The main difference is the treatment window.

A 6-month balloon creates a shorter period of restriction and habit-building. A 12-month balloon may provide a longer structured period for weight-loss support, lifestyle coaching and follow-up.

This may be helpful for selected patients who need more time to work on:

• Meal structure
• Portion control
• Emotional eating
• Physical activity
• Relapse prevention
• Long-term weight maintenance

However, a longer programme also requires stronger commitment.

Patients must be willing to continue follow-up after the initial motivation fades. Missing appointments for months can allow symptoms, nutritional issues or weight regain patterns to go unnoticed.

The question is not simply whether the balloon stays longer. The more important question is whether the patient will receive meaningful support throughout that longer period.

Adjustable Balloons and Follow-Up Decisions

Some longer-duration balloon systems may allow volume adjustment depending on device type and clinical protocol.

For example, the Spatz3 Adjustable Balloon System is designed to allow volume adjustment after placement, although the approved maximum placement duration differs by country and protocol. FDA documentation states that the maximum placement period for Spatz3 in the United States is 8 months and that the balloon must be removed at that time or earlier.[1]

In some international settings, longer-duration protocols may be discussed, but patients should confirm the exact regulatory status and recommended duration in the treatment country.

Adjustment may be considered when:

• Symptoms are too strong
• The patient is not tolerating the balloon
• Weight loss is inadequate
• The programme requires modification
• The treating team’s protocol supports adjustment

Adjustment should not be viewed as a cosmetic upgrade or a simple way to “increase results.” It is a clinical decision based on tolerance, safety, weight trajectory and the treating team’s protocol.

Who May Be Considered for a 12-Month Gastric Balloon?

A longer-duration balloon may be considered for selected adults who need a supervised non-surgical weight-loss option and are able to commit to follow-up.

It may be relevant for patients who:

• Are not ready for bariatric surgery
• Do not meet surgical criteria
• Prefer a temporary non-surgical intervention
• Need structured support for behaviour change
• Require weight reduction before another procedure
• Need a longer period of supervised lifestyle work

Suitability depends on more than BMI.

The treating team should assess:

• BMI and waist-related risk
• Weight history
• Previous weight-loss treatments
• Medical conditions
• Reflux symptoms
• Ulcer history
• Previous gastric or bariatric surgery
• Swallowing problems
• Medication use
• Pregnancy status when relevant
• Eating behaviour
• Psychological readiness
• Ability to attend follow-up
• Ability to arrange safe removal

NICE guidance on overweight and obesity management emphasizes individualized, person-centred assessment rather than a single intervention for every patient.[4] This principle applies strongly to gastric balloon treatment, where success depends on patient selection and follow-up as much as the device itself.

Who May Not Be Suitable?

A 12-month gastric balloon may not be appropriate for every patient.

Contraindications and caution factors vary according to the device and local protocol, but may include:

• Previous gastric or bariatric surgery
• Large hiatal hernia
• Active stomach ulcer disease
• Severe esophagitis
• Significant untreated reflux
• Gastrointestinal bleeding risk
• Pregnancy
• Certain inflammatory gastrointestinal conditions
• Inability to undergo endoscopy safely
• Untreated eating disorders
• Inability to follow aftercare instructions
• Inability to attend follow-up or removal

If endoscopy at the time of placement identifies ulcers, severe inflammation or other concerning findings, treatment may need to be delayed or cancelled.

This should be explained before travel so the patient understands that final suitability may depend on clinical findings on the day.

Assessment Before Placement

Assessment before a 12-month balloon should be more detailed than simply checking weight and BMI.

The team should review:

• Height, weight and BMI
• Weight history
• Previous diets and medications
• Previous balloon or bariatric treatments
• Reflux symptoms
• Ulcer history
• Swallowing problems
• Previous endoscopy findings
• Previous abdominal or gastric surgery
• Medication list
• Diabetes medication
• Blood thinners
• Anti-inflammatory medication use
• GLP-1 medication use
• Pregnancy status when relevant
• Eating behaviour
• Psychological readiness
• Follow-up availability

This assessment helps determine whether the balloon is appropriate and whether the patient can safely complete the treatment period.

For international patients, the assessment should also include practical questions:

• Can the patient attend follow-up?
• Can the patient return for removal?
• Is local removal available if needed?
• What happens if symptoms develop after returning home?
• Are local doctors familiar with the device?

These questions are not administrative details. They are part of safe medical travel planning.

Preparing for Treatment Abroad

Patients travelling internationally should receive clear preparation instructions before treatment.

A responsible plan should include:

• Confirmation of medical suitability
• Review of reflux, ulcers and previous gastric surgery
• Medication review
• Baseline tests when recommended
• Endoscopy and placement schedule
• Accommodation close to medical care
• Symptom medication plan
• Diet stage instructions
• Follow-up schedule
• Removal date and location
• Emergency contact details
• Post-removal maintenance plan

Patients should not travel for placement without knowing where and when removal will happen.

If removal is planned in the home country, this should be arranged before placement. Patients should not assume that any local endoscopy unit will automatically remove a balloon placed abroad.

Placement Day and Early Adaptation

Placement is usually performed with endoscopy under sedation or anaesthesia according to the hospital protocol.

During the procedure, the endoscopy team evaluates the upper gastrointestinal tract, places the balloon, fills it according to the device protocol and monitors the patient after recovery from sedation.

The first days can be uncomfortable.

Common early symptoms may include:

• Nausea
• Vomiting
• Cramping
• Reflux
• Burping
• Bloating
• Difficulty with intake
• Fatigue

Most patients adapt, but intolerance can occur.

Patients should receive clear medication and hydration instructions. They should also know when symptoms are no longer considered expected adaptation and require medical review.

Persistent vomiting, inability to drink, severe abdominal pain, black stools, fever or signs of dehydration should not be ignored.

The First Week Requires Practical Planning

The first week is often the most important adaptation period.

Patients may need:

• Anti-nausea medication
• Acid suppression
• Antispasmodic medication
• Hydration guidance
• Rest
• Easy access to the treating centre
• Clear escalation instructions

For patients abroad, this means travel should be scheduled carefully.

A patient who is still vomiting, unable to drink or severely weak should not be rushing to an airport. Accommodation should be close enough to medical care so that review is possible if needed.

Ongoing Tolerance During the 12-Month Period

Because a 12-month balloon remains longer than many standard balloons, ongoing tolerance matters.

Symptoms that develop months after placement should still be taken seriously.

New or worsening symptoms may include:

• Persistent vomiting
• Severe reflux
• Abdominal pain
• Black stools
• Difficulty tolerating food
• Abdominal distension
• Signs of dehydration

These symptoms are not automatically normal simply because the patient adapted well earlier.

Late symptoms may require clinical review, medication adjustment, endoscopy or early removal depending on the situation.

Nutrition and Behaviour Support

A longer programme can create a useful period for education and habit-building.

Patients should work on:

• Meal structure
• Portion control
• Protein intake
• Fluid timing
• Hunger management
• Emotional eating
• Alcohol reduction
• Sleep habits
• Gradual physical activity
• Relapse prevention

The key question is what habits will remain after removal.

A balloon creates temporary restriction. It does not permanently change appetite biology, food environment, stress eating patterns or decision-making. The programme should therefore prepare patients for life after the balloon rather than focusing only on weight loss while the device is present.

The AGA guideline on intragastric balloons emphasizes that lifestyle modification should be used together with balloon therapy.[3]

Monitoring Motivation Over a Longer Treatment Window

Motivation changes over a year.

Many patients begin strongly and then gradually drift back toward old habits once the novelty of treatment fades. This is one reason longer programmes require structured follow-up rather than occasional check-ins.

Follow-up should address real-life obstacles such as:

• Travel
• Family meals
• Work schedules
• Celebrations
• Stress eating
• Poor sleep
• Alcohol
• Sedentary routines
• Weight-loss plateaus

The value of the longer balloon period is not simply that the stomach remains occupied longer. The value is the repeated opportunity to practise new behaviours and correct problems before they become permanent patterns.

Expected Weight Loss Results

Weight loss varies between individuals.

Longer-duration balloons may provide a longer period for supervised weight-loss support, but results still depend on patient engagement, diet adherence, physical activity, follow-up and tolerance.

The ASGE–ESGE guideline provides evidence-based recommendations on endoscopic bariatric and metabolic therapies, including intragastric balloon therapy, as part of obesity management.[2]

Patients should understand that expected results are influenced by:

• Starting BMI
• Medical conditions
• Diet adherence
• Activity level
• Balloon tolerance
• Follow-up participation
• Adjustment protocol if relevant
• Maintenance plan after removal

A 12-month balloon should not be described as a guaranteed result. It should be presented as a temporary tool within a supervised programme.

Removal Planning Before Life Gets Complicated

A year is long enough for life to change.

Patients may move, change jobs, become pregnant, experience family obligations, lose insurance access, or become unable to travel back to the original centre. This is why removal logistics should be agreed before placement.

Patients should know:

• Planned removal date
• Latest acceptable removal timeframe
• Where removal will occur
• Who will perform removal
• What documents are needed
• What happens if they cannot return
• What happens if early removal is needed
• Whether local removal is available

Clear planning reduces the risk of a patient carrying a device longer than intended because the removal pathway was never organised properly.

Removal Is Part of the Treatment Contract

Removal is not a minor administrative detail.

For endoscopic balloons, removal is a planned endoscopic procedure and should occur within the recommended timeframe.

The original treatment team should provide the device details needed by any future endoscopist, including:

• Balloon type
• Fill volume if documented
• Placement date
• Planned removal date
• Adjustment history if relevant
• Medications
• Warning symptoms
• Treating centre contact details

If removal is performed in another country, the local endoscopist needs accurate information.

Patients should not treat removal as optional or something to organise at the last minute.

What If Symptoms Develop Months Later?

Symptoms that appear months after placement still require attention.

A patient who develops new persistent vomiting, severe reflux, abdominal pain, black stools, inability to eat or drink, or symptoms suggesting obstruction should seek medical review.

Possible concerns may include:

• Ulceration
• Gastritis
• Balloon intolerance
• Balloon migration
• Obstruction
• Device-related complications
• Another unrelated abdominal condition

This is especially important when the patient lives far from the original treating centre.

The plan should explain when local emergency care is needed and how the original treatment records can be shared.

Risks and Possible Complications

Like all medical procedures, 12-month balloon treatment carries potential risks.

Common side effects may include:

• Nausea
• Vomiting
• Reflux
• Cramping
• Burping
• Bloating
• Dehydration
• Balloon intolerance

Less common but more serious complications may include:

• Ulceration
• Gastritis
• Bleeding
• Aspiration
• Endoscopy-related injury
• Balloon deflation
• Balloon migration
• Gastric outlet obstruction
• Small bowel obstruction
• Need for urgent removal
• Need for endoscopic or surgical intervention

Patients should seek urgent medical attention for severe abdominal pain, persistent vomiting, inability to drink, fever, black stools, abdominal distension or inability to pass stool or gas.

A comprehensive review of intragastric balloon complications describes adverse events ranging from common gastrointestinal symptoms to severe complications requiring urgent intervention.[8]

Weight Maintenance After Removal

The end of the balloon period is a major transition.

Once the balloon is removed, the stomach is no longer occupied by the device. Appetite, portion tolerance and eating habits may change.

If the patient has not developed sustainable habits, weight regain can occur.

A maintenance plan may include:

• Written nutrition plan
• Protein targets
• Physical activity strategy
• Behavioural support
• Weight monitoring
• Follow-up appointments
• Medication review when appropriate
• Discussion of further obesity treatment if needed

The removal appointment should not be viewed as the finish line. It should be viewed as the beginning of the maintenance phase.

Planning 12-Month Balloon Treatment Abroad Responsibly

International patients should clarify practical and medical details before committing to treatment.

Important questions include:

• Which balloon system will be used?
• Is it approved for 12 months in the treatment country?
• Is the balloon adjustable?
• What is the follow-up schedule?
• What happens if symptoms are severe?
• What happens if adjustment is needed?
• When must removal occur?
• Where will removal happen?
• What if I cannot return for removal?
• What records will I receive?
• What support continues after removal?

The patient should not leave the treatment country with an implanted device and no clear long-term pathway.

How Healing Journey Supports 12-Month Balloon Patients

Healing Journey helps patients clarify device type, placement requirements, follow-up schedule, symptom support, removal planning and post-balloon maintenance before treatment begins.

Our support may include:

• Eligibility review coordination
• Appointment and endoscopy scheduling
• Travel and accommodation planning
• Medication and symptom instruction coordination
• Follow-up schedule coordination
• Removal pathway planning
• Communication after return home
• Escalation support if medical review is needed

Our focus is to make sure the balloon is part of a supervised programme, not simply a procedure performed abroad.

For a 12-month balloon, this matters even more because the patient may spend most of the treatment period outside the country where the device was placed.

References

1. U.S. Food and Drug Administration. Spatz3 Adjustable Balloon System: Instructions for Use and Premarket Approval Information. FDA documentation states the Spatz3 Adjustable Balloon permits adjustment and has a maximum placement period of 8 months in the United States.[1]
2. American Society for Gastrointestinal Endoscopy and European Society of Gastrointestinal Endoscopy. Guideline on Primary Endoscopic Bariatric and Metabolic Therapies for Adults with Obesity. Gastrointestinal Endoscopy / Endoscopy.[2]
3. American Gastroenterological Association. Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity. Gastroenterology. 2021.[3]
4. National Institute for Health and Care Excellence. NG246: Overweight and Obesity Management.[4]
5. U.S. Food and Drug Administration. Spatz3 Adjustable Balloon System PMA Database: Indications and Long-Term Supervised Diet and Behaviour Modification Programme.[5]
6. ClinicalTrials.gov. A Study to Compare the 12-Month Spatz3 Adjustable Balloon Over a 6-Month Non-Adjustable Balloon With Dietician Follow-Up. NCT04800835.[6]
7. Tate CM, Geliebter A. Intragastric Balloon Treatment for Obesity: Review of Safety and Effectiveness. Obesity Surgery.
8. Adverse Events and Complications With Intragastric Balloons: A Comprehensive Review. Obesity Surgery.
9. Lari E, Burhamah W, Lari A, et al. Intra-Gastric Balloons: The Past, Present and Future. Annals of Medicine and Surgery.